Matinas BioPharma Holdings Inc Share Price Today: Live Updates & Key Insights
Matinas BioPharma Holdings Inc share price today is $0.64, up 8.47%. The stock opened at $0.5917 against the previous close of $0.59, with an intraday high of $0.64 and low of $0.5832.
Matinas BioPharma Holdings Inc Share Price Chart
Matinas BioPharma Holdings Inc
Matinas BioPharma Holdings Inc Share Price Performance
Matinas BioPharma Holdings Inc Institutional Holdings
Matinas BioPharma Holdings Inc Market Status
Matinas BioPharma Holdings Inc Fundamentals
Market Cap 4.10 M
PB Ratio 0.6347
PE Ratio 0.0
Enterprise Value 1.00 M
Total Assets 12.64 M
Volume 29677
Matinas BioPharma Holdings Inc Company Financials
About Matinas BioPharma Holdings Inc & investment objective
Company Information Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is MAT2203, an oral formulation of amphotericin B that is starting Phase 3 clinical trials for the treatment of aspergillosis and cryptococcosis, as well as prevention of invasive fungal infections in patients due to immunosuppressive therapy. It offers MAT2501, an orally administered formulation of amikacin. The company has strategic collaborations with the National Institute of Allergy and Infectious Diseases; BioNTech SE to evaluate the combination of mRNA formats with the LNC platform; and Genentech Inc. to develop oral formulations. The company was incorporated in 2013 and is based in Bedminster, New Jersey.
Organisation Biotechnology
Employees 3
Industry Biotechnology
CEO Mr. Jerome D. Jabbour J.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Matinas BioPharma Holdings Inc FAQs
What is the share price of Matinas BioPharma Holdings Inc today?
The current share price of Matinas BioPharma Holdings Inc is $0.64.
Can I buy Matinas BioPharma Holdings Inc shares in India?
Yes, Indian investors can buy Matinas BioPharma Holdings Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Matinas BioPharma Holdings Inc shares in India?
You can easily invest in Matinas BioPharma Holdings Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Matinas BioPharma Holdings Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Matinas BioPharma Holdings Inc.
Can I buy fractional shares of Matinas BioPharma Holdings Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Matinas BioPharma Holdings Inc?
Matinas BioPharma Holdings Inc has a market cap of $4.10 M.
In which sector does Matinas BioPharma Holdings Inc belong?
Matinas BioPharma Holdings Inc operates in the Biotechnology sector.
What documents are required to invest in Matinas BioPharma Holdings Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Matinas BioPharma Holdings Inc?
The PE ratio of Matinas BioPharma Holdings Inc is N/A and the PB ratio is 0.63.